Welcome to our dedicated page for CIMPRESS plc SEC filings (Ticker: CMPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cimpress plc filings document the Irish public company's financial reporting, material events, capital structure and shareholder governance. Recent Form 8-K reports furnish quarterly earnings documents for fiscal periods, record material-event disclosures and describe capital-allocation actions such as ordinary share repurchase authorizations.
Proxy filings for Cimpress cover annual general meeting matters, board reappointments, shareholder voting items and governance procedures. The filing record also provides formal disclosure around material agreements, operating and financial results, ordinary-share capital matters and other events relevant to its web-to-print mass-customization business.
BlackRock, Inc. has filed a Schedule 13G reporting a passive ownership stake in Cimpress plc common stock. As of 12/31/2025, BlackRock reports beneficial ownership of 1,261,757 shares, representing 5.1% of the outstanding common stock.
BlackRock states it has sole power to vote 1,235,172 shares and sole power to dispose of 1,261,757 shares, with no shared voting or dispositive power. The filing explains that various underlying clients or investors have the right to receive dividends or sale proceeds, but no single person has more than five percent of Cimpress’s total outstanding common shares.
BlackRock certifies the shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of Cimpress plc.
Cimpress plc executive Florian Baumgartner reported equity transactions involving company stock. On 01/15/2026, 1,026 restricted share units automatically vested, with each RSU converting into one ordinary share at a price of $0, reflecting Cimpress’ prior commitment to issue these shares.
On the same date, 488 ordinary shares were disposed of at $79.73 per share. After these transactions, Baumgartner directly held 60,405 ordinary shares and 4,102 restricted share units. The RSU award vests over four years, with 25% of the original grant vesting on the initial vesting date and 6.25% vesting quarterly thereafter.
Cimpress plc director and 10% owner Scott J. Vassalluzzo reported multiple equity transactions in Cimpress ordinary shares on 11/15/2025. Several blocks of restricted share units (RSUs) vested, delivering 351, 1,128, 494, and 638 ordinary shares at an exercise price of $0 per share as the company fulfilled prior RSU awards. To cover obligations associated with these awards, 1,256 shares were disposed of at $66.59 per share.
Following these transactions, Mr. Vassalluzzo held 72,734 ordinary shares directly, with additional indirect beneficial ownership reported through various Prescott-related investment entities and family accounts, including 2,636,492 shares held by Prescott Associates L.P. Each RSU grant vests over four years, with 25% vesting on the initial date shown and 25% vesting on each yearly anniversary.
Cimpress plc director Dessislava Temperley reported restricted share unit (RSU) vesting and related share transactions. On 11/15/2025, RSUs vested and were exercised into 351, 1,128, 494, and 638 ordinary shares at an exercise price of $0 per share, increasing her direct holdings. On the same date, she disposed of 1,256 ordinary shares at $66.59 per share. Following these transactions, she directly beneficially owned 4,285 Cimpress ordinary shares, and continues to hold additional unvested or unexercised RSUs as shown in the derivative securities table.
Cimpress plc (CMPR) director Sophie Gasperment reported equity transactions on 11/15/2025 involving the vesting of restricted share units (RSUs) and a share sale. Several RSU awards vested and converted into ordinary shares, including 351, 1,128, 494 and 638 ordinary shares, each at an exercise price of $0 as these are RSUs rather than options. Following these transactions, she continued to hold ordinary shares directly.
The filing also shows a disposition of 1,256 ordinary shares coded “F” at a price of $66.59, typically indicating shares withheld or sold to cover taxes associated with the vesting. The RSU awards referenced in Table II vest over four years, with 25% of the original RSU grant vesting on the initial vesting date and another 25% vesting each year thereafter.
Cimpress plc CEO, Chairman and Director Robert S. Keane reported equity award activity involving performance share units (PSUs). On 11/15/2025, three PSU awards vested and were settled in ordinary shares, delivering 9,579, 146 and 3,388 ordinary shares at an exercise price of $0 per share. To cover related obligations, 5,404 ordinary shares were disposed of at $66.59 per share. Following these transactions, he directly owned 65,092 ordinary shares. He also reported substantial indirect holdings through several entities, including 220,503 shares via the Keane Family Foundation and 986,785 shares via Third Delaware 2011, LLC.
Cimpress plc executive vice president and chief technology officer Maarten Wensveen reported equity transactions in the company’s ordinary shares on 11/15/2025. Several awards of restricted share units and performance share units were exercised at an exercise price of $0, resulting in acquisitions of 1,860, 3,697, and 1,303 ordinary shares as those units vested. On the same date, 3,319 ordinary shares were disposed of at a price of $66.59 per share. Following these transactions, Wensveen directly beneficially owned 24,128 Cimpress ordinary shares.
Cimpress plc (CMPR) executive Sean E. Quinn reported equity award activity on a Form 4. On 11/15/2025, Quinn, the company’s EVP and Chief Financial Officer, exercised vested restricted share units (RSUs) and performance share units (PSUs), each representing the right to receive one ordinary share upon vesting.
The filing shows multiple “M” transactions in which RSUs and PSUs converted into ordinary shares at an exercise price of $0, and one “F” transaction in which 4,121 ordinary shares were disposed of at $66.59 per share. After these transactions, Quinn directly owned 40,883 ordinary shares and continued to hold additional RSUs and PSUs that vest over a four-year period, with 25% vesting on the listed exercisable dates and 6.25% vesting quarterly thereafter.
Cimpress plc executive reports share vesting and sale activity. On 11/15/2025, EVP and CEO, Vista, Florian Baumgartner acquired 1,691 ordinary shares from vested restricted share units and 3,550 and 1,303 ordinary shares from vested performance share units, all at an exercise price of $0. On the same date, 3,108 ordinary shares were disposed of at $66.59 per share. Following these transactions, he directly beneficially owned 59,867 Cimpress ordinary shares, along with outstanding restricted share units and performance share units that continue to vest over a four-year schedule.
Cimpress plc (CMPR) reported an insider buy by its EVP, Chief Financial Officer, Sean E. Quinn. On 11/06/2025, Quinn executed multiple open‑market purchases totaling 4,000 ordinary shares at prices ranging from $61.83 to $63.00.
Following these transactions, Quinn beneficially owned 36,484 ordinary shares, held directly, as reflected after each reported trade.